Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

2025 Jul 17, 09:10

Trump's Potential Powell Firing: Experts Warn of Severe Dollar Impact

2025 Jul 17, 08:10

Nassim Taleb Warns of US Debt and Calls Bitcoin 'Electronic Tulip'

2025 Jul 17, 06:10

TSMC's Q2 2025 Earnings Surge Driven by AI Boom, Sets New Records

Ghko B 2025 Jul 16, 16:00

Dogecoin Is Rising Today: How to Trade Dogecoin CFDs with markets.com?

crypto cfd trading
Frances Wang 2025 Jul 16, 16:00

CFD Brokers In 2025: VT Markets, markets.com, Pepperstone, XTB

cfd trading
Ghko B 2025 Jul 16, 16:00

Jensen Huang Sells Nvidia Stock: Is NVDA Stock a Buy or Hold?

stocks
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Ava Grace 2025 Jul 17, 13:20

US Consumer Spending Defies Tariff Impact: Resilience or Price Inflation?

Ava Grace 2025 Jul 17, 10:21

Gold Price Forecast 2025-2026: A Comprehensive Analysis by the World Gold Council

Sophia Claire 2025 Jul 17, 10:20

EU Prepares Retaliatory Measures Against US Amid Trade Dispute

Sophia Claire 2025 Jul 17, 07:20

Analyzing Trump's Tariff Threats: Are European Markets Underestimating the Risk?

Liam James 2025 Jul 17, 06:20

Iran's Khamenei: Ready for Stronger Response to Potential Attacks

Noah Lee 2025 Jul 17, 05:20

US House Advances Crypto Bill After Republican Standoff

Ava Grace 2025 Jul 17, 01:20

US Bankers Defend Federal Reserve Independence Amid Political Pressure

Noah Lee 2025 Jul 17, 01:20

US Economy in Uncertainty: Tariffs and Labor Shortages Worry Businesses

Info

Spread

0.29

Spread (%)

0.6044 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

95994716160

Shares Outstanding

2035079936

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-07-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0536

EPS

2.68

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Jul 16, 16:00

ASML Stock Slides 11%: Why ASML Stock Is Falling Today?

Stocks
Ghko B 2025 Jul 16, 16:00

XRP Price Hits 6-Month High: How to Trade XRP CFDs with markets.com

Crypto CFD Trading
Frances Wang 2025 Jul 16, 16:00

AI Stock CFD Trading: NVDA Stock CFD, AMZN Stock CFD, ASML Stock CFD

Trustpilot